These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22796120)

  • 1. Vein graft neointimal hyperplasia is exacerbated by CXCR4 signaling in vein graft-extrinsic cells.
    Zhang L; Brian L; Freedman NJ
    J Vasc Surg; 2012 Nov; 56(5):1390-7. PubMed ID: 22796120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells.
    Zhang L; Peppel K; Brian L; Chien L; Freedman NJ
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2277-83. PubMed ID: 15486311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte chemoattractant protein-1/CCR2 axis promotes vein graft neointimal hyperplasia through its signaling in graft-extrinsic cell populations.
    Fu C; Yu P; Tao M; Gupta T; Moldawer LL; Berceli SA; Jiang Z
    Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2418-26. PubMed ID: 22904274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor receptor-2 signaling attenuates vein graft neointima formation by promoting endothelial recovery.
    Zhang L; Sivashanmugam P; Wu JH; Brian L; Exum ST; Freedman NJ; Peppel K
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):284-9. PubMed ID: 18006858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model.
    Zhang L; Hagen PO; Kisslo J; Peppel K; Freedman NJ
    J Vasc Surg; 2002 Oct; 36(4):824-32. PubMed ID: 12368745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-9 mediates chronic kidney disease-dependent vein graft disease: a role for mast cells.
    Zhang L; Wu JH; Otto JC; Gurley SB; Hauser ER; Shenoy SK; Nagi K; Brian L; Wertman V; Mattocks N; Lawson JH; Freedman NJ
    Cardiovasc Res; 2017 Nov; 113(13):1551-1559. PubMed ID: 29048463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of endothelial CXCR4 reduces reendothelialization and enhances neointimal hyperplasia after vascular injury in atherosclerosis-prone mice.
    Noels H; Zhou B; Tilstam PV; Theelen W; Li X; Pawig L; Schmitz C; Akhtar S; Simsekyilmaz S; Shagdarsuren E; Schober A; Adams RH; Bernhagen J; Liehn EA; Döring Y; Weber C
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1209-20. PubMed ID: 24723559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice.
    Mayr U; Mayr M; Li C; Wernig F; Dietrich H; Hu Y; Xu Q
    Circ Res; 2002 Feb; 90(2):197-204. PubMed ID: 11834713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical cilostazol inhibits neointimal hyperplasia in a rat interposition vein graft model.
    Malliaris SD; Munabi NCO; Akelina Y; Ascherman JA
    Plast Reconstr Surg; 2014 Dec; 134(6):895e-901e. PubMed ID: 25415112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-extrinsic cells predominate in vein graft arterialization.
    Zhang L; Freedman NJ; Brian L; Peppel K
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):470-6. PubMed ID: 14726410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin S contributes to macrophage migration via degradation of elastic fibre integrity to facilitate vein graft neointimal hyperplasia.
    Shi HT; Wang Y; Jia LX; Qin YW; Liu Y; Li HH; Qi YF; Du J
    Cardiovasc Res; 2014 Mar; 101(3):454-63. PubMed ID: 24319016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ischemic injury on vein graft remodeling: role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation.
    Sakaguchi T; Asai T; Belov D; Okada M; Pinsky DJ; Schmidt AM; Naka Y
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):129-37. PubMed ID: 15632834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vein graft disease in a knockout mouse model of hyperhomocysteinaemia.
    Steger CM; Mayr T; Bonaros N; Bonatti J; Schachner T
    Int J Exp Pathol; 2016 Dec; 97(6):447-456. PubMed ID: 28004436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FSP-1 silencing in bone marrow cells suppresses neointima formation in vein graft.
    Cheng J; Wang Y; Liang A; Jia L; Du J
    Circ Res; 2012 Jan; 110(2):230-40. PubMed ID: 22116816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resident Arterial Cells and Circulating Bone Marrow-Derived Cells both Contribute to Intimal Hyperplasia in a Rat Allograft Carotid Transplantation Model.
    He Y; Xu X; Zhu T; Tang M; Mei J; Si Y
    Cell Physiol Biochem; 2017; 42(4):1303-1312. PubMed ID: 28715799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 2-deficiency on bone marrow-derived cells augments vascular healing of murine arterial lesions.
    Liu W; Eczko JC; Otto M; Bajorat R; Vollmar B; Roesner JP; Wagner NM
    Life Sci; 2020 Feb; 242():117189. PubMed ID: 31891724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perivascular treatment with azathioprine reduces neointimal hyperplasia in experimental vein grafts.
    Schachner T; Heiss S; Zipponi D; Tzankov A; Bernecker O; Kroell A; Laufer G; Bonatti J
    Heart Surg Forum; 2006; 9(1):E515-7. PubMed ID: 16401538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
    Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
    J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human umbilical cord blood endothelial progenitor cells decrease vein graft neointimal hyperplasia in SCID mice.
    Zhu S; Malhotra A; Zhang L; Deng S; Zhang T; Freedman NJ; Storms R; Peppel K; Goldschmidt-Clermont PJ; Dong C
    Atherosclerosis; 2010 Sep; 212(1):63-9. PubMed ID: 20451204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxc2 overexpression enhances benefit of endothelial progenitor cells for inhibiting neointimal formation by promoting CXCR4-dependent homing.
    Li D; Yan D; Liu W; Li M; Yu J; Li Y; Qu Z; Ruan Q
    J Vasc Surg; 2011 Jun; 53(6):1668-78. PubMed ID: 21514778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.